BEAT
HealthcareHeartBeam, Inc.
$2.74
+$0.31 (+12.76%)
Jan 5, 2026
Price History (1Y)
Analysis
HeartBeam, Inc. is a healthcare company in the Health Information Services industry, with a market capitalization of $94.38M and 16 employees. The company's financial health indicates significant net income loss, with a net income (TTM) of -$20,620,000 and free cash flow of -$7,698,589. The gross margin, operating margin, and profit margin are all 0.0%. Return on Equity is -792.0%, while Return on Assets is -272.4%. The company has $1.86M in cash but the debt level is not disclosed. The valuation context shows a negative forward P/E ratio of -5.17, with no dividend yield or payout ratio available. The price to book ratio is 228.33, and the beta is -0.79, indicating high volatility.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About HeartBeam, Inc.
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Visit website →Key Statistics
- Market Cap
- $94.38M
- P/E Ratio
- N/A
- 52-Week High
- $4.00
- 52-Week Low
- $0.54
- Avg Volume
- 12.88M
- Beta
- -0.79
Company Info
- Industry
- Health Information Services
- Exchange
- NCM
- Country
- United States
- Employees
- 16